Sharon Collins Presnell - Jun 23, 2021 Form 4 Insider Report for VIVEVE MEDICAL, INC. (VIVE)

Role
Director
Signature
/s/ Jim Robbins, as Attorney-in-Fact
Stock symbol
VIVE
Transactions as of
Jun 23, 2021
Transactions value $
$0
Form type
4
Date filed
6/25/2021, 04:05 PM
Next filing
Jan 6, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VIVE Non-Qualified Stock Option (Right to Purchase) Award $0 +39K $0.00 39K Jun 23, 2021 Common Stock 39K $2.73 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person is a participant in the Issuer's Amended and Restated 2013 Stock Option and Incentive Plan (the "Plan") and received 39,000 non-qualified stock options on June 23, 2021 (the "Grant Date"). The non-qualified stock options shall vest and become exercisable in 48 equal monthly installments from the Grant Date.